Skip to Content
U.S. National Institutes of Health
Last Updated: 03/24/14

Staff, Pictures and Bios

Jan Casadei, PhD, Branch Chief, RAB

Jan Casadei, PhD joined the National Cancer Institute in 1991, where she is now chief of the Regulatory Affairs Branch, CTEP. Her area of expertise covers FDA regulations, policies and guidelines for the conduct of clinical studies with investigational agents. More…

Sherry Ansher, PhD, Associate Branch Chief, RAB; Agreement Coordination Group

Dr. Sherry Ansher is the Associate Branch Chief, Agreement Coordination Group, Regulatory Affairs Branch in the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, NCI. Dr. Ansher joined CTEP in 1994 after spending a year in the Grants Associates Program of the NIH as the Coordinator of Research and Development Agreements. More…

Rita Misra, PhD, MPH, Associate Branch Chief; Toxicologist; Regulatory Affairs Professional

Rita Misra is currently serving as the Associate Branch Chief of the Drug Regulatory Group, Regulatory Affairs Branch, CTEP. She joined RAB/CTEP as a Senior Regulatory Scientist in 2001. Dr. Misra has a B.A. in Biochemistry from Rutgers University, a Ph.D. in Environmental Toxicology from Cornell University, More…

Sally Hausman, MA, Senior Specialist; R & D Agreements

Sally Hausman is a Senior Specialist for Research and Development Agreements in the Regulatory Affairs Branch of CTEP. She is responsible for obtaining access to CTEP-sponsored investigational agents on behalf of academic investigators interesting in performing preclinical studies and for executing the Material Transfer Agreements with the investigators’ institutions. More…

Michael Pelekis, PhD

Michael Pelekis, PhD, supports the interactions between the CTEP and the Center for Drug Evaluation and Research (CDER), the Center for Biologics Evaluation and Research (CBER), and the Center for Devices and Radiologic Health (CDRH) of the FDA. He helps to establish policy with the FDA for various aspects of the CTEP Investigational New Drug Applications (INDs) and assesses FDA and CTEP current policies to identify conflicts and propose solutions. More…

Bhanu Ramineni, MA

Ms. Ramineni joined the Drug Regulatory Group of the Regulatory Affairs Branch (RAB), CTEP, in 2010. She holds two Master’s degrees, one in Environmental Sciences from Nagarjuna University, India and a second one in Biochemistry and Molecular Biology with specialization in Biotechnology from Georgetown University. More…

Julie Rhie, PhD, Pharmacologist; Regulatory Affairs Professional

Julie Rhie, PhD joined the Regulatory Affairs Branch in 2001. Her role within RAB includes acting as a regulatory liaison for CTEP with the FDA and as an internal regulatory policy advisor. More…

Jian Zhang, PhD, Senior Specialist; R & D Agreements

Jian Qiao Zhang received his PhD in biochemistry from the University of Nottingham, UK. He completed his postdoctoral training at the NIH and at the American Red Cross focusing on protein-protein interactions and cancer research. More…